Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with ...

Majority of Participants Reached a Defined Threshold for Remission of Tardive Dyskinesia Regardless of Underlying Psychiatric Disorder <l ...

involuntary movements (chorea) of Huntington's disease. INGREZZA or INGREZZA SPRINKLE do not cure the cause of involuntary movements, and do not treat other symptoms of Huntington's disease ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Proficio Capital Partners LLC bought a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during ...

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine ... jerky movements known as chorea, which both affect the dopamine pathway. Crucially, the subgroup ...

The combination of chorea and dementia is reminiscent of an autosomal recessive form of Huntington disease.75 Figure 3 shows an algorithm that clinicians can use when evaluating adults presenting with ...

Planet Fitness, one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, is here to help everyone rebound and recover from ...